Posts Tagged: Michael Sefton
David Zhang (BME 2016) co-founded Revela in 2021. Recently, his company was purchased by Oddity in a $100 million deal
Two multidisciplinary teams led by U of T Engineering researchers will train a new generation of experts to address challenges in health care, from organ rejuvenation to more equitable access to treatment for heart failure.
David Zhang obtained a MASc in 2016. In 2021, David and his colleagues founded Revela, a startup company that aims to use the latest advances in Artificial Intelligence (AI) and biotechnology to create better consumer products.
New Medicine by Design-funded research out of the lab of Michael Sefton continues to advance one of his lab’s goals: developing a cell-based treatment for type 1 diabetes that can be implanted under the skin and would eliminate the need for insulin injections.
Canadian scientists made one of the most important discoveries in the history of medicine 100 years ago when Dr. Frederick Banting and his assistant, Charles Best, successfully isolated the hormone insulin in Banting's lab at the University of Toronto.
Dr. Michael Sefton had received ~ $430,000 JDRF grant to continue to study if cells found in the skin can play a key role in enabling stem cell transplants for diabetes.
Medicine by Design is supporting research aimed at advancing new concepts expected to be important to regenerative medicine in the coming years. The funded projects will have potential impacts in diseases and conditions such as vision loss, amyotrophic lateral sclerosis (ALS), intestinal disease in premature babies and more.
Engineering Professor and Alumnus Elected to the U.S. National Academy of Engineering
Researchers from IBBME developed a method to improve the transplantation success rate of artificial islets.
Dr. Michael Sefton received the Order of Canada at the end of 2017.
Showing 1 - 10 of 23 results